Stockscreener 앱 받기
1.56
0.65%
0.01
시간 외 거래:
1.55
-0.01
-0.64%
전일 마감가:
$1.55
열려 있는:
$1.56
하루 거래량:
1.81M
Relative Volume:
0.50
시가총액:
$415.18M
수익:
-
순이익/손실:
$-208.38M
주가수익비율:
-1.30
EPS:
-1.2
순현금흐름:
$-156.57M
1주 성능:
-5.45%
1개월 성능:
-3.11%
6개월 성능:
+15.56%
1년 성능:
-55.43%
1일 변동 폭
$1.52
$1.63
1주일 범위
$1.46
$1.655
52주 변동 폭
$1.105
$4.12
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
명칭
Autolus Therapeutics Plc Adr
전화
44 20 3829 6230
주소
THE MEDIAWORKS, LONDON
AUTL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.56 | 412.52M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.92 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2024-11-15 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-03-27 | 재개 | Wells Fargo | Overweight |
| 2023-03-17 | 개시 | Bryan Garnier | Buy |
| 2021-06-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-01-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 재개 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | JP Morgan | Overweight |
| 2020-07-22 | 개시 | SunTrust | Buy |
| 2020-04-22 | 개시 | Mizuho | Buy |
| 2019-09-23 | 개시 | Needham | Buy |
| 2019-05-17 | 재확인 | H.C. Wainwright | Buy |
| 2018-10-24 | 개시 | H.C. Wainwright | Buy |
모두보기
Autolus Therapeutics Plc Adr 주식(AUTL)의 최신 뉴스
Can Autolus Therapeutics plc Depositary Receipt rally from current levelsWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
Q3 EPS Estimate for Autolus Therapeutics Lifted by Analyst - Defense World
Autolus Therapeutics to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 - Barchart.com
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025 - GlobeNewswire Inc.
What RSI levels show for Autolus Therapeutics plc (Common Stock) (6A3A) stockBear Alert & Fast Moving Stock Trade Plans - newser.com
First patient dosed in Autolus’ phase 1 trial for multiple sclerosis By Investing.com - Investing.com South Africa
First patient dosed in Autolus’ phase 1 trial for multiple sclerosis - Investing.com
Longevity Biotech Surges as $72.6B Market Forecast Sparks Investment Rush - The Globe and Mail
Weiss Ratings Reaffirms “Sell (E+)” Rating for Allurion Technologies (NYSE:ALUR) - Defense World
BNP Paribas SA (OTCMKTS:BNPQY) Short Interest Update - Defense World
Analysts Set Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Target Price at $9.12 - Defense World
Short Interest in Taikisha Ltd (OTCMKTS:TKIAF) Expands By 62.0% - Defense World
Wealth Enhancement Advisory Services LLC Sells 548 Shares of SPDR S&P Global Natural Resources ETF $GNR - Defense World
Goldman Sachs Group Inc. Has $78,000 Stock Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
Is CVR stock at risk of policy regulationJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Short interest data insights for PRMEPortfolio Performance Summary & Community Trade Idea Sharing - newser.com
Will iRobot Corporation see short term momentumBond Market & Smart Investment Allocation Insights - newser.com
Will HVAC stock outperform energy sector in 2025Market Performance Report & High Accuracy Trade Alerts - newser.com
Can Sanyo Chemical Industries Ltd. (XSI) stock reach $200 price target2025 Volatility Report & Fast Entry High Yield Tips - newser.com
What MACD signals say about Funko Inc.2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
William Blair Keeps Their Buy Rating on Autolus Therapeutics (AUTL) - The Globe and Mail
Autolus Therapeutics’ (AUTL) “Outperform” Rating Reaffirmed at William Blair - Defense World
Income MSTR Etf forming a bottoming basePortfolio Value Report & Risk Adjusted Swing Trade Ideas - newser.com
How institutional ownership impacts Entrada Therapeutics Inc. stock2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Short Interest Down 32.1% in August - MarketBeat
Bradstreet Holdings Inc. and competitorsJobs Report & Verified Momentum Stock Ideas - newser.com
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives $9.12 Consensus Target Price from Brokerages - MarketBeat
Will Autolus Therapeutics plc Depositary Receipt see short term momentumJobs Report & Community Consensus Trade Signals - newser.com
Quantitative breakdown of The AES Corporation recent movePortfolio Return Report & Consistent Income Trade Ideas - newser.com
Innovative Therapeutics Pipeline Positions Industry For Strong Market Growth - Barchart.com
Should you wait for a breakout in MSP Recovery Inc. Equity Warrant2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth15.09.25News - Ariva
How to build a dashboard for TRNS stockEarnings Risk Report & Safe Entry Zone Identification - newser.com
MAI Capital Management Sells 294,460 Shares of Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
Vident Advisory LLC Buys Shares of 155,504 Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
What are the risks of holding FLYY2025 Big Picture & Short-Term Trading Opportunity Alerts - Lancaster City Council
Autolus Therapeutics Q2 Earnings Call Highlights Growth and Challenges - AInvest
Real time pattern detection on World Acceptance Corporation stockJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Aug Macro: What is the next catalyst for The Toronto Dominion BankRate Cut & Reliable Momentum Entry Alerts - خودرو بانک
How to track smart money flows in BNZIJuly 2025 Volume & AI Optimized Trade Strategies - Newser
Affinity Asset Advisors LLC Sells 1,455,000 Shares of Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
PLOW recovery potential after sell offWeekly Investment Report & Growth Oriented Trading Recommendations - Newser
Price momentum metrics for HIG.PRG explainedMarket Trend Report & Growth Focused Entry Reports - Newser
Analyzing recovery setups for Autolus Therapeutics plc Depositary Receipt investorsRate Hike & High Accuracy Buy Signal Tips - Newser
Applying Elliott Wave Theory to Travel + Leisure Co.July 2025 Rallies & Comprehensive Market Scan Reports - Newser
AUTL’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Can machine learning forecast MNDR recoveryJuly 2025 EndofMonth & Real-Time Sentiment Analysis - Newser
What makes TFIN stock price move sharplyJuly 2025 Macro Moves & Advanced Technical Signal Analysis - Newser
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of “Buy” by Brokerages - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Sees Strong Trading Volume on Earnings Beat - MarketBeat
Q3 EPS Forecast for Autolus Therapeutics Raised by Analyst - Defense World
Autolus Therapeutics Plc Adr (AUTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):